|
|
|
Volumn 7, Issue 6, 1998, Pages 251-266
|
|
Pathogenesis of diabetic neuropathy;Pathogenese der diabetischen neuropathie
|
|
Author keywords
Diabetic neuropathy; Metabolic factors; Pathogenesis; Treatment; Vascular factors
|
|
Indexed keywords
17,20 DIMETHYL 7 THIAPROSTAGLANDIN E1 METHYL ESTER;
ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM);
ALDOSE REDUCTASE INHIBITOR;
ANTIOXIDANT;
CARVEDILOL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FLURBIPROFEN;
GAMMA LINOLENIC ACID;
GLUCOCORTICOID;
ILOPROST;
IMMUNOGLOBULIN;
IMMUNOSUPPRESSIVE AGENT;
INOSITOL;
LISINOPRIL;
N(G) NITROARGININE;
NERVE GROWTH FACTOR;
NEUROTROPHIN 3;
NITRIC OXIDE SYNTHASE INHIBITOR;
POLYOL;
PRIMROSE OIL;
PROSTAGLANDIN DERIVATIVE;
PROSTAGLANDIN E1 DERIVATIVE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PROTEIN KINASE C;
SOMATOMEDIN C;
SORBITOL;
THIOCTIC ACID;
TRANDOLAPRIL;
UNINDEXED DRUG;
VASODILATOR AGENT;
ANIMAL MODEL;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETES MELLITUS;
DIABETIC NEUROPATHY;
DISEASE CLASSIFICATION;
HUMAN;
HYPERGLYCEMIA;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NEUROLOGICAL COMPLICATION;
NONHUMAN;
OXIDATIVE STRESS;
PATHOGENESIS;
PROSTAGLANDIN METABOLISM;
PROTEIN EXPRESSION;
RAT;
|
|
EID: 0032553403
PISSN: 09420037
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (134)
|
